ritonavir

Generic: ritonavir

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ritonavir
Generic Name ritonavir
Labeler camber pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ritonavir 100 mg/1

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-597
Product ID 31722-597_f5490379-7440-5901-e053-2a95a90ac1f4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204587
Listing Expiration 2026-12-31
Marketing Start 2018-09-17

Pharmacologic Class

Established (EPC)
cytochrome p450 3a inhibitor [epc] protease inhibitor [epc]
Mechanism of Action
hiv protease inhibitors [moa] cytochrome p450 3a inhibitors [moa] cytochrome p450 2d6 inhibitors [moa] cytochrome p450 2c19 inducers [moa] cytochrome p450 3a inducers [moa] p-glycoprotein inhibitors [moa] breast cancer resistance protein inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] cytochrome p450 1a2 inducers [moa] cytochrome p450 2c9 inducers [moa] cytochrome p450 2b6 inducers [moa] udp glucuronosyltransferases inducers [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722597
Hyphenated Format 31722-597

Supplemental Identifiers

RxCUI
900575
UPC
0331722597302 0331722597128
UNII
O3J8G9O825
NUI
N0000000246 N0000191001 N0000175889 N0000190114 N0000182137 N0000185607 N0000190118 N0000185503 N0000190113 N0000182141 N0000191266 N0000185507 N0000187064 N0000190117

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ritonavir (source: ndc)
Generic Name ritonavir (source: ndc)
Application Number ANDA204587 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 120 TABLET in 1 BOTTLE (31722-597-12)
  • 30 TABLET in 1 BOTTLE (31722-597-30)
source: ndc

Packages (2)

31722-597-12 120 TABLET in 1 BOTTLE (31722-597-12) 31722-597-30 30 TABLET in 1 BOTTLE (31722-597-30)

Ingredients (1)

ritonavir (100 mg/1)

Linked Drug Pages (1)

Ritonavir ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f5490379-7440-5901-e053-2a95a90ac1f4", "openfda": {"nui": ["N0000000246", "N0000191001", "N0000175889", "N0000190114", "N0000182137", "N0000185607", "N0000190118", "N0000185503", "N0000190113", "N0000182141", "N0000191266", "N0000185507", "N0000187064", "N0000190117"], "upc": ["0331722597302", "0331722597128"], "unii": ["O3J8G9O825"], "rxcui": ["900575"], "spl_set_id": ["db633374-6d8e-4622-9fe1-f9d68baa59bb"], "pharm_class_epc": ["Cytochrome P450 3A Inhibitor [EPC]", "Protease Inhibitor [EPC]"], "pharm_class_moa": ["HIV Protease Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "UDP Glucuronosyltransferases Inducers [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (31722-597-12)", "package_ndc": "31722-597-12", "marketing_start_date": "20180917"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (31722-597-30)", "package_ndc": "31722-597-30", "marketing_start_date": "20180917"}], "brand_name": "Ritonavir", "product_id": "31722-597_f5490379-7440-5901-e053-2a95a90ac1f4", "dosage_form": "TABLET", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 3A Inhibitor [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Protease Inhibitor [EPC]", "UDP Glucuronosyltransferases Inducers [MoA]"], "product_ndc": "31722-597", "generic_name": "Ritonavir", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ritonavir", "active_ingredients": [{"name": "RITONAVIR", "strength": "100 mg/1"}], "application_number": "ANDA204587", "marketing_category": "ANDA", "marketing_start_date": "20180917", "listing_expiration_date": "20261231"}